This week, the 2026 LSX Nordic Congress was held in Copenhagen. Find out what came out of the Nordic-focused partnering event.
The post LSX Nordic Congress 2026: what came out of the biotech partnering event appeared first on
Subscribe to Labiotech.eu’s news feed.
Click on “Follow” and decide if you want to get news from Labiotech.eu via RSS, as email newsletter, via mobile or on your personal news page.
Subscription to Labiotech.eu comes without risk as you can unsubscribe instantly at any time.
You can also filter the feed to your needs via topics and keywords so that you only receive the news from Labiotech.eu which you are really interested in. Click on the blue “Filter” button below to get started.
Title: Labiotech.eu
Is this your feed? Claim it!
This week, the 2026 LSX Nordic Congress was held in Copenhagen. Find out what came out of the Nordic-focused partnering event.
The post LSX Nordic Congress 2026: what came out of the biotech partnering event appeared first on
Our two guests this week: Quin Wills, CEO of Ochre Bio, and Stéphane Barges, CEO of Lexogen.
The post The problem at the heart of drug discovery: Lexogen & Ochre Bio on the power of AI ...
For nearly thirty years, there have been no FDA-approved drugs for pattern hair loss, but this could change soon as therapies near approval.
The post Treating pattern hair loss: how close are we? appeared first...
As Sweden's life sciences sector continues to grow, we explore 8 biotech companies in Sweden that are leading the way in the industry.
The post Eight Swedish companies spearheading the country’s biotech scene appeared first on
Delve into the field of RAS inhibitors, an area of biotechnology that is increasingly diversifying to tackle pancreatic cancer, among other cancers.
The post RAS inhibition enters its second wave appeared first on